Bumper Offer - Urjas oil Just @ Rs. 1
Migarid 5 Tablet, a prescription drug, is manufactured in various forms such as Tablet. Primarily, it is used for the treatment of Migraine.
Medical history of the patient along with age and gender determines the dosage of Migarid 5 Tablet. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Some other side effects of Migarid 5 Tablet have been listed ahead. Usually, these side effects of Migarid 5 Tablet go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Migarid 5 Tablet has a Unknown effect for pregnant women and Unknown effect on lactating mothers. Warnings related to Migarid 5 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Migarid 5 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Depression, Parkinson's Disease are examples of such conditions. Other contraindications of Migarid 5 Tablet have been discussed in the sections ahead.
Drug reaction of Migarid 5 Tablet with other medicines has been reported. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Migarid 5 Tablet is not safe while driving, and is is not addictive in nature.
Migarid 5 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Migarid 5 Tablet safe for pregnant women?
No research has not been done till date on the safety of Migarid for pregnant women. So its effects on pregnant women are unknown.
Is the use of Migarid 5 Tablet safe during breastfeeding?
No research work has been carried out till date on effect of Migarid on breastfeeding women. So it is not known whether taking Migarid will cause side effects or not.
What is the effect of Migarid 5 Tablet on the Kidneys?
Migarid may have mild side effects on the kidneys.
What is the effect of Migarid 5 Tablet on the Liver?
Very few cases of side effects of Migarid on the liver have been reported.
What is the effect of Migarid 5 Tablet on the Heart?
There may be an adverse effect on the heart after taking Migarid. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Migarid 5 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Migarid 5 Tablet unless your doctor advises you to do so -
Is this Migarid 5 Tablet habit forming or addictive?
Migarid 5 Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Migarid 5 Tablet. So it is best to avoid driving.
Is it safe?
Yes, Migarid 5 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Migarid 5 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Migarid 5 Tablet
There isn't any research available on the side effects of taking Migarid 5 Tablet with food.
Interaction between Alcohol and Migarid 5 Tablet
It is difficult to say anything about the effect of Migarid 5 Tablet and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 180
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 180
